Telomir Pharmaceuticals said Chief Scientific Advisor Itzchak Angel will serve as plenary lecturer and session chair at a women’s health and breast cancer conference in Tokyo. He is set to present Telomir-Zn in triple negative breast cancer.
published
Telomir Pharmaceuticals said Chief Scientific Advisor Itzchak Angel will serve as plenary lecturer and session chair at a women’s health and breast cancer conference in Tokyo. He is set to present Telomir-Zn in triple negative breast cancer.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.